Melatonin in Pulmonary Arterial Hypertension: A Promising Adjunctive Therapy.
作者信息
Yar Shaher, Rafieossadat Seyed R, Tadayon Taraneh, Shahriar Zahin
机构信息
University College of Medicine and Dentistry Lahore Pakistan.
Shiraz Neuroscience Research Center Shiraz University of Medical Sciences Shiraz Iran.
出版信息
Pulm Circ. 2025 Jul 23;15(3):e70139. doi: 10.1002/pul2.70139. eCollection 2025 Jul.
Abstract
摘要
相似文献
1
Melatonin in Pulmonary Arterial Hypertension: A Promising Adjunctive Therapy.褪黑素在肺动脉高压中的应用：一种有前景的辅助治疗方法。
Pulm Circ. 2025 Jul 23;15(3):e70139. doi: 10.1002/pul2.70139. eCollection 2025 Jul.
2
Melatonin Improves Quality of Life, Oxidative Stress, and Cardiovascular Function in Pulmonary Arterial Hypertension.褪黑素改善肺动脉高压患者的生活质量、氧化应激及心血管功能。
Pulm Circ. 2025 Jun 19;15(2):e70109. doi: 10.1002/pul2.70109. eCollection 2025 Apr.
3
Use of melatonin as adjunctive therapy in neonatal sepsis: A systematic review and meta-analysis.褪黑素辅助治疗新生儿败血症的系统评价和荟萃分析。
Complement Ther Med. 2018 Aug;39:131-136. doi: 10.1016/j.ctim.2018.06.002. Epub 2018 Jun 11.
4
Melatonin against pulmonary arterial hypertension: is it ready for testing in patients?褪黑素治疗肺动脉高压：是否已准备好进行患者临床试验？
Cardiovasc J Afr. 2021 Mar-Apr;32(2):111-112. doi: 10.5830/CVJA-2021-008.
5
Contribution of reactive oxygen species to the pathogenesis of pulmonary arterial hypertension.活性氧在肺动脉高压发病机制中的作用
PLoS One. 2017 Jun 30;12(6):e0180455. doi: 10.1371/journal.pone.0180455. eCollection 2017.
6
Appraisal and evaluation of the quality of life in pulmonary arterial hypertension instruments: A systematic review using COSMIN methodology.肺动脉高压工具的生活质量评估和评价：采用 COSMIN 方法的系统评价。
Respir Med. 2024 Nov-Dec;234:107829. doi: 10.1016/j.rmed.2024.107829. Epub 2024 Oct 6.
7
StratosPHere 2: study protocol for a response-adaptive randomised placebo-controlled phase II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by mutations in BMPR2.StratosPHere 2：一项针对 BMPR2 基因突变导致的肺动脉高压的羟氯喹和苯丁酸钠的反应适应性随机安慰剂对照 II 期试验的研究方案。
Trials. 2024 Oct 15;25(1):680. doi: 10.1186/s13063-024-08485-z.
8
Endothelin receptor antagonists for pulmonary arterial hypertension.用于治疗肺动脉高压的内皮素受体拮抗剂。
Cochrane Database Syst Rev. 2013 Feb 28;2013(2):CD004434. doi: 10.1002/14651858.CD004434.pub5.
9
Colchicine as a therapeutic possibility for the treatment of pulmonary arterial hypertension (PAH) in a rat model.秋水仙碱作为大鼠模型中治疗肺动脉高压（PAH）的一种治疗可能性。
Biochem Pharmacol. 2025 Sep;239:117058. doi: 10.1016/j.bcp.2025.117058. Epub 2025 Jun 24.
10
Clinical efficacy of melatonin as adjunctive therapy to non-surgical treatment of periodontitis: a systematic review and meta-analysis.褪黑素作为牙周炎非手术治疗辅助疗法的临床疗效：系统评价和荟萃分析。
Inflammopharmacology. 2022 Jun;30(3):695-704. doi: 10.1007/s10787-022-00959-3. Epub 2022 Mar 15.
本文引用的文献
1
Melatonin Improves Quality of Life, Oxidative Stress, and Cardiovascular Function in Pulmonary Arterial Hypertension.褪黑素改善肺动脉高压患者的生活质量、氧化应激及心血管功能。
Pulm Circ. 2025 Jun 19;15(2):e70109. doi: 10.1002/pul2.70109. eCollection 2025 Apr.
2
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237.
3
Melatonin and Cardioprotection in Humans: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.褪黑素与人类心脏保护：随机对照试验的系统评价与荟萃分析
Front Cardiovasc Med. 2021 May 12;8:635083. doi: 10.3389/fcvm.2021.635083. eCollection 2021.
4
Health-related Quality of Life and Survival in Pulmonary Arterial Hypertension.肺动脉高压患者的健康相关生活质量与生存情况
Ann Am Thorac Soc. 2016 Jan;13(1):31-9. doi: 10.1513/AnnalsATS.201412-572OC.
Zotero 插件